FDA Week - 11/30/2018

After geneticist sparks controversy by editing human embryos . . .

Gottlieb Condemns Embryo Editing; Urges Strict Enforcement And Ousting

November 29, 2018
FDA Commissioner Scott Gottlieb on Wednesday (Nov. 28) took to Twitter to condemn a Chinese researcher who made headlines after announcing he had edited the genes of a set of twin girls born this month using the CRISPR-Cas 9 gene editing tool. Gottlieb called on the scientific community to enforce “without mercy” strict standards on the use of gene editing technologies and argued that scientists should oust anyone who uses the technology to edit human embryos. Similarly, National Institutes of...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.